Interspecies scaling: predicting clearance of drugs in humans. Three different approaches

References

• Bachmann K. Predicting toxiokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species. Journal of Applied Toxicology 1989; 9: 331–338
   PubMedGoogle Scholar
• Bialer M. Comparative pharmacokinetics of the newer antiepileptic drugs. Clinical Pharmacokinetics 1993; 6: 441–452
   Google Scholar
• Bonati M., Latini R., Tognoni G. Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse. Drug Metabolism Reviews 1984–85; 15: 1355–1383
   PubMed Web of Science ®Google Scholar
• Boxenbaum H., Fertig J. B. Scaling of antipyrine intrinsic clearance of unbound drug on 15 mammalian species. European Journal of Drug Metabolism and Pharmacokinetics 1984; 9: 177–183
   PubMed Web of Science ®Google Scholar
• Boxenbaum H., Murray W., Markin R., Ciraulo D. Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs, G. Barnett, C. C. Nora. Biomedical Publications, Forest City, California 1985; 93
   Google Scholar
• Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. Journal of Pharmacokinetics and Biopharmacy 1980; 8: 165–176
   PubMedGoogle Scholar
• Boxenbaum H., Dilea C. First-time-in-human dose selection: Allometric thoughts and perspectives. Journal of Clinical Pharmacology 1975; 35: 957–966
   Google Scholar
• Brazell R. K., Pask Y. H., Woolridge C. B., McCue B., Basker R., Couch R., York B. Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors. Drug Metabolism Dispersion 1990; 18: 435–440
   PubMedGoogle Scholar
• Cook C. S., Rozek L. F., Stolzenbach J., Anderson S., Schoenhard G. L., Kasion A. Pharmacokinetics of a novel antiarrhythmic drug, actisomide. Pharmaceutical Research 1993; 10: 427–433
   PubMed Web of Science ®Google Scholar
• Cruze C. A., Kelm G. R., Meredith M. P. Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology. Pharmaceutical Research 1995; 12: 895–901
   PubMedGoogle Scholar
• Duthu G. S. Interspecies correlation of the pharmacokinetics of erythromycin, oleandomycin, and tylosin. Journal of Pharmaceutical Sciences 1985; 74: 943–946
   PubMed Web of Science ®Google Scholar
• Eldon M. A., Battle M. M., Coon M. J., Nordblom G. D., Sedmen A. J., Colburn W. A. Clinical Pharmacokinetics and relative bioavailability of oral procaterol. Pharmaceutical Research 1993; 10: 603–605
   PubMedGoogle Scholar
• El Sayed M. A., Loscher W., Frey H. H. Pharmacokinetics of ethosuximide in the dog. Archives in International Pharmacodynamics 1978; 234: 180–192
   PubMedGoogle Scholar
• Evans G. H., Nies A. S., Shaud D. G. The disposition of propranolol. III. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. Journal of Pharmacology and Experimental Therapeutics 1973; 186: 114–122
   PubMed Web of Science ®Google Scholar
• Gascon R. A., Calvo B., Hernandez R. M., Dominguez-Gil A., Pedraz J. Interspecies scaling of cimetidine-theophylline pharmacokinetic interaction: Interspecies scaling in pharmacokinetic interaction. Pharmaceutical Research 1994; 11: 945–950
   PubMedGoogle Scholar
• Goodman and Gilman's, The Pharmacological basis of Therapeutics, eighth edition, A. Goodman Gilman, T. W. Rall, A. S. Nies, P. Taylor. McGraw-Hill, Inc, New York 1993; 1674, 1680
   Google Scholar
• Guentert T. W., Huang J. D., Qie S. Disposition of quinidine in the rabbit. Journal of Pharmaceutical Sciences 1982; 71: 812–815
   PubMedGoogle Scholar
• Heusner A. A. What does the power function reveal about structure and function in animal of different size. Annual Reviews in Physiology 1987; 78: 121–133
   Google Scholar
• Ishigami M., Saburomani K., Niino K., Kido M., Morita S., Miyamoto G., Kohn H. Pharmacokinetics of procaterol in the rat, rabbit and beagle dog. Arzneimittelforschung 1979; 29: 266–270
   PubMedGoogle Scholar
• Iven H. The pharmacokinetics and organ distribution of ajmaline and quinidine in the mouse. Naumyn-Schmiedberg's Archives in Pharmacology 1977; 298: 43–50
   PubMedGoogle Scholar
• Kawakaini J., Yamamoto K., Swada Y., Iga T. Prediction of brain delivery of ofloxacin, a new quinolone, in the human from animal data. Journal of Pharmacokinetics and Biopharmacy 1994; 22: 207–227
   PubMedGoogle Scholar
• King F. G., Dedrick R. L., Farris F. F. Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum (II) (DDP) in several species. Journal of Pharmacokinetics and Biopharmacy 1986; 14: 131–155
   PubMedGoogle Scholar
• Klotz U., Antonin K. H., Bieck P. R. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. Journal of Pharmacology and Experimental Therapeutics 1976; 199: 67–73
   PubMed Web of Science ®Google Scholar
• Antiepileptic Drugs, 3rd edition, R. H. Levy, F. F. Dreifuss, R. H. Matison, B. Meldrum, J. K. Penry. Raven Press, New York 1989
   Google Scholar
• Metabolism of Antiepileptic Drugs, R. H. Levy, W. H. Pitlick, M. Eichelbaum, J. Meijer. Raven Press, New York 1984
   Google Scholar
• Loscher W. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse. Journal of Pharmacology and Experimental Therapeutics 1978; 204: 255–261
   PubMed Web of Science ®Google Scholar
• Mahmood I., Balian J. D. Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance. Journal of Pharmaceutical Sciences 1996; 85: 411–414
   PubMed Web of Science ®Google Scholar
• Matsumoto K., Miyazaki H., Fuji T., Maeda T., Hashimoto M. Absorption, distribution and excretion of 3-(sulfamoyl[14C]methyl)-1,2-benzisoxazole (AD-810) in rats, dogs and monkeys and of AD-810 in men. Arzneimittelforschung 1983; 33: 961–967
   PubMed Web of Science ®Google Scholar
• McGovern J. P., Williams M. G., Stewart J. C. Interspecies comparison of acivicin pharmacokinetics. Drug Metabolism and Disposition 1988; 16: 18–22
   PubMed Web of Science ®Google Scholar
• McNamara P. J. Interspecies scaling in pharmacokinetics. Pharmaceutical Bioequivalence, G. Peter, L. S. Tse Welling, Francis, V. Dighe Shrikant. Marcel Dekker Inc, New York 1991
   Google Scholar
• Montay G., Goueffon Y., Rooquet F. Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans. Antimicrobial Agents and Chemistry 1984; 25: 463–472
   PubMed Web of Science ®Google Scholar
• Mordenti J. Pharmacokinetic scale up: accurate prediction of human pharmacokinetic profiles from animal data. Journal of Pharmaceutical Sciences 1985; 74: 1097–1099
   PubMed Web of Science ®Google Scholar
• Owens S. M., Hardwick W. C., Blackall D. Phencyclidine pharmacokinetic scaling among species. Journal of Pharmacology and Experimental Therapeutics 1987; 242: 96–101
   PubMedGoogle Scholar
• Paxton J. W., Kim S. N., Whitfield L. R. Pharmacokinetic and toxicity of the antitumor agents amascrine and CI-921, a new analogue, in mice, rats, rabbits, dogs and humans. Cancer Research 1990; 50: 2692–2697
   PubMed Web of Science ®Google Scholar
• Sacher G. Relation of lifespan to brain weight and body weight in mammals. CIBA Foundation Colloquia on Aging, G. E. W. Wolstenholme, M. O'Connor. Churchill, London 1959; 115–133
   Google Scholar
• Sangaili L., Bortollotti A., Jiritano L., Bonati M. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans. Drug Metabolism and Disposition 1988; 16: 749–753
   PubMedGoogle Scholar
• Streeter A. J. Dept of Drug Metabolism. The R. W. Johnson Pharmaceutical Research Institute, Spring House 1995, PA 10477. Personal communication
   Google Scholar
• Swada Y., Hanano M., Sugiyama Y., Iga T. Prediction of the disposition of β-lactam antibiotics in humans from phari-nacokinetic parameters in animals. Journal of Pharmacokinetics and Biopharmacy 1984; 12: 241–261
   PubMedGoogle Scholar
• Swada Y., Hanano M., Sugiyama Y., Iga T. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats. Journal of Pharmacokinetics and Biopharmacy 1985; 13: 477–492
   PubMedGoogle Scholar
• Tanaka Y., Shimojyo H., Hata T., Hashimoto M., Noguchi H. Toxicokinetrics of zenarestat, an aldose reductase inhibitor in animals and man. Xenobiotica 1994; 5: 461–471
   Google Scholar
• Ueda C. T., Ballard B. E., Rowland M. Concentration-time effects on quinidine disposition kinetics in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 1977; 200: 459–468
   PubMedGoogle Scholar